Dianthus Therapeutics (NASDAQ:DNTH) Announces Earnings Results, Misses Expectations By $0.11 EPS
Dianthus Therapeutics (NASDAQ:DNTH – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.97) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.86) by ($0.11), Zacks reports. The firm had revenue of $0.40 million for the quarter, compared to analyst estimates of $0.58 million. Dianthus Therapeutics had […]
6 Nov 12:06 · The Cerbat Gem